Inventor
GARCIA-MARTINEZ LEON F
US73 patents
⚠️ This page may combine multiple inventors who share the name “GARCIA-MARTINEZ LEON F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALDERBIO HOLDINGS LLC
27 patentsUS10533048B2Jan 14, 2020
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC11 citations94
US10066009B2Sep 4, 2018
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC19 citations94
US9085615B2Jul 21, 2015
Antibodies to IL-6 to inhibit or treat inflammation
ALDERBIO HOLDINGS LLC29 citations93
US10214582B2Feb 26, 2019
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC12 citations92
US10208112B2Feb 19, 2019
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC12 citations92
US10189895B2Jan 29, 2019
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC12 citations92
US10179809B2Jan 15, 2019
Anti-CGRP compositions and use thereof
ALDERBIO HOLDINGS LLC13 citations92
US9957321B2May 1, 2018
Anti-IL-6 antibodies for the treatment of oral mucositis
ALDERBIO HOLDINGS LLC15 citations92
US9884912B2Feb 6, 2018
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC15 citations92
US9481725B2Nov 1, 2016
Antibodies to HGF and compositions containing
ALDERBIO HOLDINGS LLC16 citations92
US9255154B2Feb 9, 2016
Anti-PCSK9 antibodies and use thereof
ALDERBIO HOLDINGS LLC36 citations92
US9518082B2Dec 13, 2016
Antibody purification and purity monitoring
ALDERBIO HOLDINGS LLC16 citations91
US10533045B2Jan 14, 2020
Antibody purification and purity monitoring
ALDERBIO HOLDINGS LLC12 citations84
US10391169B2Aug 27, 2019
Method of treating allergic asthma with antibodies to IL-6
ALDERBIO HOLDINGS LLC4 citations84
US10100108B2Oct 16, 2018
Antibodies to HGF and compositions containing
ALDERBIO HOLDINGS LLC6 citations84
US9783603B2Oct 10, 2017
Therapeutic use of antibodies to HGF
ALDERBIO HOLDINGS LLC5 citations84
US9062104B2Jun 23, 2015
Therapeutic use of antibodies to HGF
ALDERBIO HOLDINGS LLC10 citations84
US10844116B2Nov 24, 2020
Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
ALDERBIO HOLDINGS LLC3 citations83
US9834603B2Dec 5, 2017
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC7 citations83
US10266587B2Apr 23, 2019
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
ALDERBIO HOLDINGS LLC12 citations82
US10913794B2Feb 9, 2021
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC2 citations73
US10227402B2Mar 12, 2019
Anti-NGF antibodies and anti-NGF antibody fragments
ALDERBIO HOLDINGS LLC1 citations73
US9879074B2Jan 30, 2018
Antibodies to IL-6 and use thereof
ALDERBIO HOLDINGS LLC4 citations73
US9732150B2Aug 15, 2017
Therapeutic use of antibodies to HGF
ALDERBIO HOLDINGS LLC6 citations73
US11117960B2Sep 14, 2021
Humanized anti-ACTH antibodies and use thereof
ALDERBIO HOLDINGS LLC2 citations72
US10259885B2Apr 16, 2019
Anti-PCSK9 antibodies and use thereof
ALDERBIO HOLDINGS LLC4 citations70
US9738713B2Aug 22, 2017
Methods of preventing or treating pain using anti-NGF antibodies
ALDERBIO HOLDINGS LLC1 citations63
H LUNDBECK AS
9 patentsUS11993648B2May 28, 2024
Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
H LUNDBECK AS3 citations85
US11938185B2Mar 26, 2024
Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
H LUNDBECK AS3 citations85
US10975135B2Apr 13, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10968268B2Apr 6, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US10954285B2Mar 23, 2021
Humanized anti-PACAP antibodies
H LUNDBECK AS4 citations84
US12162936B2Dec 10, 2024
Methods of treatment with anti-PACAP antibodies
H LUNDBECK AS2 citations73
US10981985B2Apr 20, 2021
Anti-PACAP antibodies
H LUNDBECK AS2 citations73
US11325967B2May 10, 2022
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers
H LUNDBECK AS1 citations71
US12077581B2Sep 3, 2024
Anti-PACAP antibodies and uses thereof
H LUNDBECK AS0 citations62
ALDER BIOPHARMACEUTICALS INC
6 patentsUS10913783B2Feb 9, 2021
Humanized anti-PACAP antibodies and uses thereof
ALDER BIOPHARMACEUTICALS INC4 citations83
US10981984B2Apr 20, 2021
Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion
ALDER BIOPHARMACEUTICALS INC3 citations82
US11254741B2Feb 22, 2022
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72
US10899834B2Jan 26, 2021
Anti-PACAP antibodies
ALDER BIOPHARMACEUTICALS INC2 citations72
US10544214B2Jan 28, 2020
Humanized anti-ACTH antibodies and use thereof
ALDER BIOPHARMACEUTICALS INC2 citations71
US10047157B2Aug 14, 2018
Humanized anti-ACTH antibodies and use thereof
ALDER BIOPHARMACEUTICALS INC2 citations71
RUSSO ANDREW F
2 patentsUS9855332B2Jan 2, 2018
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
RUSSO ANDREW F18 citations91
US9708393B2Jul 18, 2017
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
RUSSO ANDREW F19 citations89
GARCIA-MARTINEZ LEON F
2 patentsLATHAM JOHN A
1 patentSMITH JEFFREY T L
1 patentKOVACEVICH BRIAN ROBERT
1 patentDUTZAR BENJAMIN H
1 patentShowing the top 50 of 73 patents by PatentIndex Score.